S5 Ep20: Sherman Spotlights Advances With RET Inhibitors in Medullary Thyroid Cancer

OncLive® On Air - A podcast by OncLive® On Air

Podcast artwork

Dr. Sherman discusses the incidence of RET fusions in medullary thyroid cancer and the current clinical landscape of RET inhibitors in the field.